State Street Corp Renalytix PLC Transaction History

State Street Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.45 - $7.81 $460 - $1,468	-188 Reduced 0.89%	20,905 $51,000
Q1 2022 May 16, 2022	BUY	$5.88 - $15.9 $45,552 - $123,177	7,747 Added 58.05%	21,093 $146,000
Q4 2021 Feb 14, 2022	BUY	$13.43 - $27.4 $3,303 - $6,740	246 Added 1.88%	13,346 $212,000
Q3 2021 Nov 15, 2021	BUY	$17.91 - $34.78 $234,621 - $455,618	13,100 New	13,100 $263,000

554K

Ticker RNLX
Exchange OTC
Sector Healthcare
Industry Health Information Services
Shares Outstandng 37,445,900
Market Cap $5.62M
Description
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.